Show simple item record

Authordc.contributor.authorIñíguez Vila, Germán 
Authordc.contributor.authorGallardo, Pedro 
Authordc.contributor.authorCastro, Juan José 
Authordc.contributor.authorGonzález, René 
Authordc.contributor.authorGarcía, Mirna 
Authordc.contributor.authorKakarieka, Elena 
Authordc.contributor.authorSan Martín, Sebastián 
Authordc.contributor.authorJohnson, María Cecilia 
Authordc.contributor.authorMericq, Verónica 
Authordc.contributor.authorCassorla Goluboff, Fernando 
Admission datedc.date.accessioned2019-10-22T03:15:03Z
Available datedc.date.available2019-10-22T03:15:03Z
Publication datedc.date.issued2019
Cita de ítemdc.identifier.citationFrontiers in Endocrinology, Volumen 10, Issue JAN, 2019,
Identifierdc.identifier.issn16642392
Identifierdc.identifier.other10.3389/fendo.2018.00797
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/172071
Abstractdc.description.abstractIntroduction: Fetal growth restriction may be the consequence of maternal, fetal, or placental factors. The insulin-like growth factors (IGFs) are major determinants of fetal growth, and are expressed in the mother, fetus and placenta in most species. Previously we reported higher placental protein content of IGF-I, IGF-IR, and AKT in small (SGA) compared with those from appropriate for gestational age (AGA) placentas. The protein Klotho, has been reported in placenta and may regulate IGF-I activity. In this study we determined Klotho gene expression and protein immunostaining in term (T-SGA y T-AGA) and preterm (PT-SGA y PT-AGA) human placentas. In addition, we assessed the effect of Klotho on the IGF-IR and AKT activation induced by IGF-I. Methods: Placentas (n = 1 17) from 32 T-SGA (birth weight (BW) = −1.74 ± 0.08 SDS), 37 T-AGA (BW = 0.12 ± 0.12 SDS), 20 PT-SGA (BW = −2.08 ± 0.14 SDS), and 28 PT-AGA (BW = −0.43 ± 0.13 SDS) newborns were collected. mRNA expression by RT-PCR in the chorionic (CP) and basal (BP) plates of the placentas, and the presence of Klotho was evaluated by immunohistochemistry (integral optical density, IOD). In addition, we developed placental explants that were incubated with IGF-I in the presence or absence of Klotho. Results: We found a lower mRNA expression and protein immunoreactivity of Klotho in the CP of SGA (term and preterm) compared with AGA placentas. We also observed a significant reduction in IGF-IR tyrosine activation induced by IGF-I 10 nM when preincubated with 2.0 nM of Klotho (2.4 ± 0.5 arbitrary units vs. 1.3 ± 0.3 AU), and similar results we observed on AKT and ERK42/44 activation. Conclusion: We describe for the first time that Klotho mRNA and protein varies according to fetal growth and gestational age. In addition, Klotho appears to down-regulate the activation induced by IGF-I on IGF-IR and AKT, suggesting that Klotho may be regulating IGF-I activity in human placentas according to intrauterine fetal growth.
Lenguagedc.language.isoen
Publisherdc.publisherFrontiers Media
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
Sourcedc.sourceFrontiers in Endocrinology
Keywordsdc.subjectFetal growth
Keywordsdc.subjectIGF-I
Keywordsdc.subjectIGF-IR
Keywordsdc.subjectKlotho
Keywordsdc.subjectPlacenta
Keywordsdc.subjectSmall for gestation age (SGA)
Títulodc.titleKlotho gene and protein in human placentas according to birth weight and gestational age
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorlaj
Indexationuchile.indexArtículo de publicación SCOPUS
uchile.cosechauchile.cosechaSI


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile